These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10850551)

  • 1. Elevated serum levels of astroglial S100beta in patients with liver cirrhosis indicate early and subclinical portal-systemic encephalopathy.
    Wiltfang J; Nolte W; Otto M; Wildberg J; Bahn E; Figulla HR; Pralle L; Hartmann H; Rüther E; Ramadori G
    Metab Brain Dis; 1999 Dec; 14(4):239-51. PubMed ID: 10850551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of astroglial S100-beta and neuron-specific enolase in hepatic encephalopathy patients.
    Saleh A; Kamel L; Ghali A; Ismail A; El Khayat H
    East Mediterr Health J; 2007; 13(5):1114-23. PubMed ID: 18290405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy.
    Duarte-Rojo A; Ruiz-Margáin A; Macias-Rodriguez RU; Cubero FJ; Estradas-Trujillo J; Muñoz-Fuentes RM; Torre A
    World J Gastroenterol; 2016 May; 22(17):4397-402. PubMed ID: 27158209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disorders and portal-systemic encephalopathy following transjugular intrahepatic portosystemic stent shunt in patients with liver cirrhosis. Relation to plasma tryptophan.
    Wiltfang J; Nolte W; von Heppe J; Bahn E; Pilz J; Hajak G; Rüther E; Ramadori G
    Adv Exp Med Biol; 1999; 467():169-76. PubMed ID: 10721053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.
    Kanner AA; Marchi N; Fazio V; Mayberg MR; Koltz MT; Siomin V; Stevens GH; Masaryk T; Aumayr B; Vogelbaum MA; Barnett GH; Janigro D
    Cancer; 2003 Jun; 97(11):2806-13. PubMed ID: 12767094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum S100beta protein concentrations following severe head injury in humans: a biochemical marker of brain death?
    Regner A; Kaufman M; Friedman G; Chemale I
    Neuroreport; 2001 Mar; 12(4):691-4. PubMed ID: 11277565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt.
    Jalan R; Gooday R; O'Carroll RE; Redhead DN; Elton RA; Hayes PC
    J Hepatol; 1995 Dec; 23(6):697-705. PubMed ID: 8750169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome.
    Jönsson H; Johnsson P; Alling C; Bäckström M; Bergh C; Blomquist S
    Ann Thorac Surg; 1999 Dec; 68(6):2202-8. PubMed ID: 10617003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100beta or melanoma inhibitory activity (MIA)?
    Deichmann M; Benner A; Kuner N; Wacker J; Waldmann V; Näher H
    Melanoma Res; 2001 Jun; 11(3):291-6. PubMed ID: 11468518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of the S100β protein as a marker of brain damage in traumatic brain injury.
    Egea-Guerrero JJ; Revuelto-Rey J; Murillo-Cabezas F; Muñoz-Sánchez MA; Vilches-Arenas A; Sánchez-Linares P; Domínguez-Roldán JM; León-Carrión J
    Brain Inj; 2012; 26(1):76-82. PubMed ID: 22149446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt].
    Chu J; Sun X; Piao L; Chen Z; Huang H; Lu C; Xu J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.
    Vos PE; van Gils M; Beems T; Zimmerman C; Verbeek MM
    Eur J Neurol; 2006 Jun; 13(6):632-8. PubMed ID: 16796588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearance of hepatic encephalopathy and improvement of liver function after surgical treatment of portal-systemic shunt in a patient with liver cirrhosis.
    Moriya K; Kojima H; Matsumura M; Sakurai S; Imazu H; Uemura M; Honda H; Fukui H
    Hepatogastroenterology; 2003; 50(52):1128-32. PubMed ID: 12845996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
    Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy.
    Hassoun Z; Deschênes M; Lafortune M; Dufresne MP; Perreault P; Lepanto L; Gianfelice D; Bui B; Pomier-Layrargues G
    Am J Gastroenterol; 2001 Apr; 96(4):1205-9. PubMed ID: 11316171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100beta induces neuronal cell death through nitric oxide release from astrocytes.
    Hu J; Ferreira A; Van Eldik LJ
    J Neurochem; 1997 Dec; 69(6):2294-301. PubMed ID: 9375660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.